Chinese Manufacturer Receives Warning Letter for API, GMP Violations

Drug Industry Daily
A A
The FDA hit the Dongying Tiandong Pharmaceutical Co. with a warning letter for failing to investigate and document out-of-specification results when testing drug batches as well as GMP violations.

To View This Article:

Login

Subscribe To Drug Industry Daily